Ambu A/S (CPH:AMBU.B)
Denmark · Delayed Price · Currency is DKK 70.50
+0.35 (0.50%)
Aug 28, 2026, 4:59 PM CET
Ambu A/S Financials Overview
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 6,237 | 6,037 | 5,391 | 4,775 | 4,444 | 4,013 |
Revenue Growth | 4.68% | 11.98% | 12.90% | 7.45% | 10.74% | 12.50% |
Gross Profit Gross Profit Growth | 3,749 | 3,633 | 3,201 | 2,713 | 2,554 | 2,503 |
Operating Income Operating Income Growth | 705 | 784 | 645 | 302 | 122 | 340 |
Net Income Net Income Growth | 510 | 609 | 235 | 168 | 93 | 247 |
Earnings Per Share EPS Growth | 1.92 | 2.28 | 0.88 | 0.64 | 0.37 | 0.98 |
EPS Growth | 43.07% | 159.09% | 37.50% | 74.79% | -62.64% | 1.03% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Respiratory Respiratory Growth | 1,933 | 1,818 | 1,645 | 1,487 | 1,447 | - |
Urology (URO), Ear-Nose-Throat (ENT), and Gastroenterology (GI) Urology (URO), Ear-Nose-Throat (ENT), and Gastroenterology (GI) Growth | 1,984 | 1,826 | 1,545 | 1,200 | 877 | - |
Anesthesia Anesthesia Growth | 1,185 | 1,249 | 1,155 | 1,093 | 1,126 | 997 |
Patient Monitoring Patient Monitoring Growth | 1,135 | 1,144 | 1,046 | 995 | 994 | 848 |
Revenue (Total) Revenue (Total) Growth | 6,237 | 6,037 | 5,391 | 4,775 | 4,444 | 4,013 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 705 | 866 | 615 | 157 | 187 | 64 |
Total Debt Total Debt Growth | 579 | 547 | 558 | 584 | 1,845 | 825 |
Net Cash (Debt) Net Cash Growth | 126 | 319 | 57 | -427 | -1,658 | -761 |
Net Cash Growth | -41.94% | 459.65% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.47 | 1.19 | 0.21 | -1.64 | -6.52 | -3.01 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 941 | 791 | 813 | 518 | 95 | 328 |
Capital Expenditures CapEx Growth | -204 | -117 | -88 | -71 | -138 | -176 |
Free Cash Flow Free Cash Flow Growth | 737 | 674 | 725 | 447 | -43 | 152 |
Free Cash Flow Growth | 16.80% | -7.03% | 62.19% | - | - | 0.66% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Gross Margin | 60.11% | 60.18% | 59.38% | 56.82% | 57.47% | 62.37% |
Operating Margin | 11.30% | 12.99% | 11.96% | 6.33% | 2.74% | 8.47% |
Pretax Margin | 10.63% | 12.51% | 5.56% | 4.40% | 2.45% | 7.68% |
Profit Margin | 8.18% | 10.09% | 4.36% | 3.52% | 2.09% | 6.16% |
FCF Margin | 11.82% | 11.16% | 13.45% | 9.36% | -0.97% | 3.79% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.410 | 0.410 | 0.380 | - | - | 0.290 |
Dividend Per Share Growth | 7.89% | 7.90% | - | - | - | 0% |
Dividend Yield | 0.54% | 0.45% | 0.29% | - | - | 0.15% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | 36.73 | 40.51 | 148.67 | 117.08 | 181.46 | 195.01 |
Forward PE | 24.46 | 33.25 | 56.17 | 68.78 | 86.13 | 92.46 |
P/FCF Ratio | 25.24 | 36.60 | 48.19 | 44.00 | - | 316.90 |
PS Ratio | 2.98 | 4.09 | 6.48 | 4.12 | 3.80 | 12.00 |